IMS Health Holdings (IMS) Shares are Up 4.86%

IMS Health Holdings (IMS) : Traders are bullish on IMS Health Holdings (IMS) as it has outperformed the S&P 500 by a wide margin of 11.32% in the past 4 weeks. The bullishness in the stock continues even in the near-term as the stock has returned an impressive 4.92%, relative to the S&P 500. The stock has continued its bullish performance both in the near-term and the medium-term, as the stock is up 4.86% in the last 1 week, and is up 15.06% in the past 4 weeks. Buying continues as the stock moves higher, suggesting a strong appetite for the stock.

The stock has recorded a 20-day Moving Average of 8.11% and the 50-Day Moving Average is 14.27%. IMS Health Holdings, Inc. is up 12.69% in the last 3-month period. Year-to-Date the stock performance stands at 17.86%.


IMS Health Holdings (NYSE:IMS): On Fridays trading session , Opening price of the stock was $29.65 with an intraday high of $30.1. The bears continued to sell at higher levels and eventually sold the stock down to an intraday low of $29.41. However, the stock managed to close at $30.02, a loss of 0.17% for the day. On the previous day, the stock had closed at $30.07. The total traded volume of the day was 1,119,129 shares.

IMS Health Holdings, Inc. (IMS) is an information and technology services company that provides solutions to its clients in the healthcare industry. The Company has its presence in over 100 countries. The Companys data set contains over 10 petabytes of data and over 500 million patient records. The Company serves healthcare organizations and life science companies, including pharmaceutical, biotechnology, consumer health and medical device manufacturers, as well as distributors, providers, payers, government agencies, policymakers, researchers and the financial community. The Companys principal offerings include national information offerings, sub-national information offerings, workflow analytics, real-world evidence (RWE) solutions, technology and applications and clinical solutions.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.